2O - Somatic mutations in BRCA2, NFE2L2, ARID1A and NOTCH1 sensitize to anti-PDL1 therapy in multiple tumor types

Autor: Kuziora, M., Si, H., Higgs, B., Brohawn, P., Streicher, K., Jure-Kunkel, M., Raja, R., Helman, E., Franovic, A., Cooper, Z., Shrestha, Y., Holoweckyj, N., Lee, Y., Achour, I., Ye, J., Mukhopadhyay, P., Dennis, P.A., Melillo, G., Abdullah, S.E., Ranade, K.
Zdroj: In Annals of Oncology December 2018 29 Supplement 10:x1-x1
Databáze: ScienceDirect